Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies
Kathleen Wantoch von Rekowski(University of Bonn), Gerd Bendas(University of Bonn)
Cited by 16
Related Papers
Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells—Deciphering Novel Potential Targets for a Cell Sensitization
|Cancers|2018|34
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding
|International Journal of Molecular Sciences|2020|30
A biscarbene gold(I)-NHC-complex overcomes cisplatin-resistance in A2780 and W1 ovarian cancer cells highlighting pERK as regulator of apoptosis
|Cancer Chemotherapy and Pharmacology|2023|12
SLFN11 and ATR as targets for overcoming cisplatin resistance in ovarian cancer cells
|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2024|6